Introduction
Eukaryotic cells have evolved mechanisms, commonly referred to as checkpoints, that monitor their readiness to enter the next stage of the cell cycle (Elledge, 1996; Paulovich et al., 1997) . The spindle checkpoint is a conserved function in eukaryotic cells that delays the onset of anaphase until the microtubules are properly connected to all chromosomes. Genetic analyses have identi®ed at least seven distinct yeast genes (BUB1, 2, and 3, MAD1, 2, and 3, and MPS1) that are important in regulating the spindle checkpoint (Hoyt et al., 1991; Li and Murray, 1991) . Recently, several research groups have identi®ed and characterized several mammalian counterparts of the spindle checkpoint components (Jin et al., 1998; Li and Benezra, 1996; Taylor and McKeon, 1997; Cahill et al., 1998) . The human MAD1 protein is hyper-phosphorylated during S, G 2 and mitosis, and it undergoes dramatic subcellular translocalization during mitosis (Jin et al., 1998) . The loss of human MAD1 function, due to sequestration by T cell leukemia viral product Tax, appears to be responsible for The transformation of T cells by The tumor virus (Jin et al., 1998) . The human MAD2 protein, structurally and functionally conserved (Li and Benezra, 1996) , is localized at the kinetochore after chromosome condensation but not after metaphase (Li and Benezra, 1996) . In addition, MAD2 associates with anaphase promoting complex (APC) (Li et al., 1997) , and the association is mediated by p55CDC (Kallio et al., 1998) . Puri®ed MAD2 is capable of arresting cycling Xenopus egg extracts at metaphase and blocking cyclin B degradation by preventing its ubiquitination (Li et al., 1997) . Microinjection of a MAD2 antibody into Ptk cells in mitosis induces premature anaphase . Both murine and human BUB1 genes have recently been cloned and characterized (Taylor and McKeon, 1997; Cahill et al., 1998; Ouyang et al., 1998) . Murine and human BUB1 proteins also localize to the kinetochore during early mitosis and spindle checkpoint activation (Taylor and McKeon, 1997; Ouyang et al., 1998) . The human BUB1 gene has recently been implicated in the development of certain colorectal cancer (Cahill et al., 1998; Lengauer et al., 1998) .
BUBR1 encodes a protein of 120 kDa whose amino acid sequences resemble both MAD3 and BUB1 of the budding yeast (Cahill et al., 1998; Ouyang et al., 1998) . Structural abnormalities have been detected in BUBR1 gene isolated from colorectal cancer samples (Cahill et al., 1998) , suggesting that it may also play a tumorsuppressing role. We (Li et al., 1999) and others (Jablonski et al., 1998) have shown that BUBR1 is hyperphosphorylated during spindle checkpoint activation. BUBR1 hyperphosphorylation induced by nocodazole is rapid, and recombinant BUBR1 is capable of autophosphorylation (Li et al., 1999) . A recent study has demonstrated that hBUBR1 is essential for spindle checkpoint function and that APC may be the target of the spindle checkpoint kinase (Chan et al., 1999) .
The mechanism by which the activated mitotic checkpoint arrests cycle progression has been under intensive investigation. Recently, it has been shown that MAD2 controls the activity of CDC20/Slp1, a WD repeat protein required for exit from mitosis (Hwang et al., 1998) . p55CDC is a mammalian homolog of CDC20 of the budding yeast (Weinstein, 1997; Weinstein et al., 1994) . The p55CDC protein mediates association of MAD2 to APC and is required for the metaphase and anaphase transition (Kallio et al., 1998) . It is also implicated in regulation of apoptosis in myeloid cells (Kao et al., 1996) . Early studies have shown that high levels of p55CDC are detected in proliferating cells and that it is associated with protein kinase activities (Weinstein et al., 1994) . Micro-injection of an anti-p55CDC antibody into mammalian cells either blocks cells at metaphase or impairs late mitotic events (Kallio et al., 1998) . Our current studies demonstrate that p55CDC is physically associated with BUBR1, suggesting that BUBR1's role in spindle checkpoint regulation may be mediated through p55CDC.
Results
Mammalian cells contain two structural homologs of yeast BUB1 (Cahill et al., 1998) . To study whether human BUBR1 plays a role in spindle checkpoint activation, we transfected HeLa cells with a construct expressing BUBR1 or BUBR1 K795M . Expression of BUBR1 alone increased the mitotic index of the transfected cells as compared with that of the control cells (Table 1) . Similarly, upon Noc treatment more M phase cells were accumulated in BUBR1 transfected, but not in BUBR1
K795M
-transfected cells, as compared with the vector-transfected control (Table 1) , suggesting that BUBR1 kinase activity plays a role in regulating spindle checkpoint. This observation is also consistent with a recent report by Yen's group that hBUBR1 is essential for spindle checkpoint activation (Chan et al., 1999) .
In order to gain insights into the biological function of BUBR1 during spindle checkpoint activation, it is important to identify proteins interacting with the kinase. The interaction between yeast MAD3 and CDC20 (Hwang et al., 1998) prompted us to investigate the association between BUBR1 and p55CDC/hCDC20. BUBR1 cDNA was fused to the DNA-binding domain of yeast Gal4 transcription factor, and p55CDC was fused to the transcriptional activator domain of the yeast protein. The fusion proteins were examined for their ability to drive the expression of lacZ reporter gene when expressed singly or in combination in a yeast two-hybrid system. Figure  1a shows that co-expression of BUBR1 and p55CDC Puri®ed GST-p55CDC (lanes 3 and 4), GSTTyro3 (lanes 1 and 2) and GST (lanes 5 and 6) were analysed by SDS ± PAGE. Partial degradation was observed with GST-Tyro3 and GST-p55CDC. M stands for molecular marker standards. (c) GST-p55CDC beads (lanes 3 and 4), as well as GST-Tyro3 (lanes 1 and 2) and GST (lanes 5 and 6) beads, were incubated with interphase and Noc-treated HeLa cell lysates. Proteins interacting with GST-p55CDC, GST-Tyro3 and GST were analysed by SDS ± PAGE followed by immunoblotting using the anti-BUBR1 antibody. Lanes 7 and 8 are the interphase and Noc-treated cell lysates BUBR1 and spindle checkpoint H Wu et al greatly activated the expression of b-Gal, suggesting that BUBR1 interacted with p55CDC. The interaction between BUBR1 and p55CDC was rather strong evidenced as high b-Gal activities (Table 2) . We then expressed and puri®ed a fusion protein of glutathione s-transferase and p55CDC (GST-p55CDC, Figure 1b , lanes 3 and 4). GST pull-down experiments showed ( Figure 1c ) that GST-p55CDC (lanes 3 and 4), but not GST alone (lanes 5 and 6) or GST-Tyro3 (lane 1 and 2) used as a negative control, brought down the BUBR1 antigen.
To determine whether p55CDC and BUBR1 interact with each other in a high eukaryotic cell system, we infected sf-9 cells with recombinant BUBR1 and/or p55CDC baculoviruses. BUBR1 expression was reported elsewhere (Li et al., 1999) , and p55CDC expression was con®rmed by Western blotting ( Figure  2a , lane 3). After con®rming the expression of p55CDC, recombinant baculovirus-infected cell lysates, as well as the control cell lysates, were immunoprecipitated with the anti-p55CDC antibody followed by Western blot analysis using the anti-BUBR1 antibody. We observed that p55CDC immunoprecipitated from cells infected with both p55CDC and BUBR1 baculoviruses ( Figure 2b , lane 2), but not from the vector-infected cells (lane 1) or from cells infected with p55CDC baculoviruses alone (lane 3), contained BUBR1 antigen. This indicates that p55CDC is associated with BUBR1 in sf-9 cells when they were co-expressed.
To address whether native BUBR1 and p55CDC interact, we performed co-immunoprecipitation experiments using HeLa cell lysates. Figure 3a shows that p55CDC immunoprecipitates (lanes 5 and 6), but not interleukin-3 (IL-3) immunoprecipitates (lanes 3 and 4) used as negative controls, contained the BUBR1 antigen. Both non-phosphorylated and phosphorylated BUBR1 were co-immunoprecipitated by the antip55CDC antibody although more BUBR1 was coimmunoprecipitated by the p55CDC antibody from mitotic cells (lane 6) than interphase cells (lane 5). Reciprocal experiments were performed to determine whether BUBR1 immunoprecipitates also contained the p55CDC antigen. We observed that p55CDC from both control and Noc-treated cells migrated at the same position as immunoglobulin G (IgG) on SDSpolyacrylamide gels (data not shown). Hence, it is dicult to detect p55CDC antigen in BUBR1 immunoprecipitates by Western blotting. To further con®rm the physical association of BUBR1 with cellular p55CDC, puri®ed His6-BUBR1 was immobilized onto Ni-NTA beads, which was subsequently incubated with HeLa cell lysates. Figure 3b shows that His6-BUBR1 resins (lanes 1 and 3), but not control resins alone (lanes 2 and 4), brought down the native p55CDC antigen from HeLa cell lysates, again con®rming the association between p55CDC and BUBR1. 
Liquid b-Gal assays were performed using ONPG as a substrate according to the protocol provided by the supplier (Clontech). pCL-1 expresses a full-length yeast b-Gal enzyme. pLAM5-1 expresses lamin fused in-frame to DNA-binding domain To determine whether the interaction is correlated with spindle checkpoint activation, we incubated His6-BUBR1 resins with equal amounts of lysates from interphase or Noc-treated HeLa cells. Figure 4a shows that His6-BUBR1 pulled down signi®cantly more p55CDC from mitotically-arrested cells (lane 3) than that from interphase cells (lanes 1). APC is an eector of spindle checkpoint components. Figure 4b ,c show that His6-BUBR1 resins, but not the resins alone, also brought down CDC27 and CDC16, two APC components. Interestingly, His6-BUBR1 preferentially interacted with hyperphosphorylated CDC27 (lane 3) although signi®cant amounts of nonphosphorylated form of CDC27 were present at Noc-treated (lane 6), as well as interphase (lane 5), cell lysates.
Early studies have shown that p55CDC is associated with unknown protein kinase activities (Weinstein et al., 1994) and highly phosphorylated during the G 2 (Weinstein, 1997; Weinstein et al., 1994) . We asked whether BUBR1 might be a candidate kinase that directly phosphorylated p55CDC. In vitro kinase assays using puri®ed recombinant proteins showed (Figure 5a ) that His6-BUBR1 (lane 3), but not His6-BUBR1 K795M (lane 4), strongly phosphorylated GST-p55CDC. No phosphorylation of GST alone by BUBR1 was observed (lane 1), suggesting that p55CDC may be an in vivo target of BUBR1
Immunocomplex kinase assays indicate that immunoprecipitated BUBR1 was active and the activity was inhibited by staurosporine ( Figure 5b) . Therefore, as an alternative method to demonstrate phosphorylation of p55CDC by the spindle checkpoint kinase, BUBR1 immunoprecipitated from equal amounts of interphase and Noc-treated HeLa cells were subject to in vitro kinase assays without addition of an exogenous substrate. Figure 6c shows that a protein that migrated at 55 kDa was coimmunoprecipitated with and phosphorylated by BUBR1 (lane 2) in vitro. Phosphorylation of the 55 kDa protein was higher in BUBR1 immunoprecipitates from Noc-treated cells (Figure 5c , lane 1), suggesting that cellular p55CDC protein was co-immunoprecipitated and phosphorylated by BUBR1. This notion was further supported by reciprocal immunocomplex kinase assays using the p55CDC antibody. Figure 5c shows that p55CDC was associated with a kinase that phosphorylated p55CDC in vitro (lane 4). An increase in the phosphorylated state of p55CDC was again detected with the immunoprecipitates from nacodazole-treated cells (lane 3). This suggests that either the p55CDC-associated kinase is more active or more p55CDC protein was interacting with the kinase or both. Anti-Prk antibody (lanes 5 and 6), used as a negative control, did not bring down the kinase activity that phosphorylates a protein migrating at or around 55 kDa. Thus, the above observations, coupled with the fact that p55CDC immunoprecipitates contain BUBR1 antigen (Figure 3a) , support the notion that BUBR1 may phosphorylate p55CDC in vivo during spindle checkpoint activation. 3 and 4) , or anti-Prk (lanes 5 and 6) antibody as controls. Immunoprecipitates were subject to in vitro immunocomplex kinase assays followed SDS ± PAGE and autoradiography
Discussion
Several groups have recently cloned BUBR1 (alternatively named MAD3, MAD3L, or SSK1 (Cahill et al., 1998; Taylor et al., 1998; Donadelli et al., 1998) . Although BUBR1 has been implicated in the spindle checkpoint control (Cahill et al., 1998; Taylor et al., 1998) , little was known regarding its regulation and mode of action during the spindle checkpoint activation. We have explored the interaction of the human BUBR1 with p55CDC, an activator of APC. Using a yeast two-hybrid system we found a strong interaction between BUBR1 and p55CDC. Subsequent GST pulldown experiments also showed the interaction of p55CDC with BUBR1. The speci®c association between BUBR1 and p55CDC was further con®rmed with co-expression of these proteins in sf-9 cells and with co-immunoprecipitation from HeLa cell lysates. Both non-phosphorylated and phosphorylated forms of BUBR1 are associated with p55CDC ( Figure 3a , lane 6). On the other hand, signi®cantly more mitotic p55CDC than the interphase one is brought down by His6-BUBR1 (Figure 3a) . This may be due simply to the fact that more p55CDC is expressed in mitotic cells (Figure 3a , lanes 5 and 6). Chan et al. have shown that native hBUBR1 forms two complexes during mitosis (Chan et al., 1999) . It would be important to examine which complex contains p55CDC. BUBR1 also pulls down both CDC16 and CDC27 and the hyperphosphorylated mitotic form of CDC27 appears to be preferentially interacting with BUBR1 (Figure 4) . Thus, it is of great signi®cance to examine the speci®c interaction between BUBR1 and APC components during spindle checkpoint activation. Because p55CDC is reported to associate with APC components (Kallio et al., 1998) , we are not clear at this moment whether BUBR1 directly interacts with CDC16 and CDC27 or mediated by p55CDC.
The interaction between yeast MAD3 and CDC20 appears to be cell cycle-dependent, peaking during mitosis (Hwang et al., 1998) . It has been shown that CDC20 is a target of the yeast spindle checkpoint (Hwang et al., 1998) . Human p55CDC is a phosphoprotein and the phosphorylation peaks at G 2 (Weinstein, 1997; Weinstein et al., 1994) . The phosphorylation drops signi®cantly as the cell enters mitosis (Weinstein, 1997) . Moreover, it has been shown that p55CDC connects MAD2 to APC (Kallio et al., 1998) . Thus, our observations that BUBR1 interacts with and phosphorylates p55CDC and that it also interacts with CDC27 and CDC16 suggest that BUBR1 may function as an important regulatory component in relaying spindle checkpoint signals to APC through p55CDC, thereby arresting cell cycle progression. Recently, Farruggio et al. have shown that aurora2/Aik kinase associates with Cdc20/p55CDC in human somatic cells and that Cdc20/p55CDC-associated aurora kinase activity peaks at G2 phase of the cell cycle (Farruggio et al., 1999) . It is possible that protein kinases other than BUBR1 are also involved in regulating p55CDC activity because early studies have demonstrated that p55CDC is associated with more than one protein kinase activities (Weinstein, 1997; Weinstein et al., 1994) .
Puri®ed BUBR1 phosphorylates p55CDC in vitro and this is supported by immunocomplex kinase assays ( Figure 5 ). It appears that the ability to phosphorylate p55CDC in BUBR1 immunoprecipitates is greater in Noc-treated cells than in interphase cells (Figure 5c ). However, the increase may be proportional to the greater amount of p55CDC. Thus, whether there is a speci®c increase in the BUBR1 activity associated with p55CDC after spindle checkpoint activation remains to be elucidated. Kotani et al. have reported that p55CDC/CDC20 is phosphorylated by other cellular kinases such as Cdc2/cyclin B, polo-like kinase (Plk), and protein kinase A (PKA) and the phosphorylation of p55CDC is required for APC activation during cell cycle progression (Kotani et al., 1999) . It is anticipated that APC activity is negatively regulated by the spindle checkpoint kinase. Thus, BUBR1 should phosphorylate p55CDC on a site(s) dierent from that phosphorylated by Cdc2/cyclin B or Plk. A comparison of phosphopeptide maps of in vivo labeled p55CDC of normal M-phase cells or Noc-treated cells and p55CDC phosphorylated in vitro by BUBR1 should provide insights into the signi®cance of p55CDC phosphorylation by BUBR1.
Mammalian cells apparently have at least two genes, BUB1 and BUBR1, whose amino acid sequences are related to yeast BUB1 (Cahill et al., 1998) . Although both BUB1 and BUBR1 gene products are essential for spindle checkpoint function (Cahill et al., 1998; Chan et al., 1999 ) the exact biochemical function of these two kinases and their hierarchy in the checkpoint pathway remain to be elucidated. Human BUBR1 also shares a strong amino acid sequence homology with yeast MAD3 (Taylor et al., 1998) . To date, no other MAD3-related genes have been identi®ed in mammals. Considering overall conservation of spindle checkpoint genes from yeast to human, it remains possible that BUBR1 is a mammalian counterpart of yeast MAD2. Our current observation that BUBR1 is directly associated with and involved in regulating p55CDC support this possibility because yeast genetic studies have shown that MAD3 is downstream of other checkpoint genes such as BUB1, MAD1 and MAD2 and that MAD3 directly interacts with CDC20 gene product.
Defects in mitotic checkpoint have been implicated in causing chromosomal instability, and eventually malignant transformation. To date, an increasing amount of evidence indicated that structural alterations or loss of functional spindle checkpoint components may result in certain cancer (Cahill et al., 1998; Lengauer et al., 1998) . In fact, aneuploidy was often observed in many types of cancer. Although the physiological and molecular basis for this abnormality remains unclear recent studies have provided strong evidence that chromosomal instability is tightly associated with the loss of functional spindle checkpoint (Jin et al., 1998; Cahill et al., 1998) . For example, several mutations have been detected in BUB1 and BUBR1 in colorectal cancers, and these mutations have functionally inactivated these checkpoint kinases (Cahill et al., 1998) . In addition, a spindle checkpoint failure facilitates transformation of cells that lacks Brca2, a breast cancer susceptibility gene (Lee et al., 1999) . Thus, a further study of BUBR1's mode of action during spindle checkpoint activation may aid us to ®nd new targets for cancer intervention.
Materials and methods

Cell culture
HeLa cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics (100 mg/ml penicillin and 50 mg/ml streptomycin sulfate). Mitotic cells were collected by shake-o after nocodazole (Noc, 0.4 mg/ml for 16 h) treatment and interphase cell lysates were prepared from the adherent fraction of untreated HeLa cells. Cell cycle status was con®rmed by¯ow cytometric analyses of propidium iodide (PI)-stained cells.
Western blotting
Cells were lysed in a lysis buer essentially as described (Ouyang et al., 1998) . Equal amounts of protein were analysed by SDS ± PAGE followed by Western blotting. The protein blots were ®rst probed with a rabbit anti-BUBR1 (1 : 500 dilution) or a goat anti-p55CDC (1 mg/ml, Santa Cruz Inc.) antibody and then with a goat-anti-rabbit or a rabbit anti-goat IgG conjugated with horse-radish peroxidase. The speci®c signals on the blot were detected with enhanced chemiluminescent method.
Transfection and flow cytometry
HeLa cells were transfected with pcDNA3-BUBR1 or pcDNA3-BUBR1 K795M or with the pcDNA3 vector alone using lipofectamine (GIBCO ± BRL, Grand Island, NY, USA) as a transfection vehicle. A cDNA encoding a kinase defective BUBR1 (BUBR1 K795M ) was generated using a sitedirected mutagenesis kit (Strategene). Transfectants were selected by addition of G418 (250 mg/ml) to the culture medium. The stably-transfected cells were treated with or without Noc for 16 h and the cell cycle status was analysed by¯ow cytometry after staining with PI.
Immunoprecipitation and immunocomplex kinase assays
Equal amounts of HeLa protein lysates (about 2 mg) were supplemented with an anti-BUBR1 antiserum (1 : 250 dilution) or an anti-p55CDC (1 mg/ml) antibody, and incubated overnight at 48C. Protein A/G agarose beads (25 ml) were then added to each immunoprecipitation mixture and the incubation continued at room temperature for 1 h or at 48C for 2 h. Immunoprecipitates were collected, washed three times with the lysis buer, and analysed by SDS ± PAGE followed by Western blotting. For kinase assays, equal amounts of HeLa cell lysates were immunoprecipitated with the anti-BUBR1 or the anti-p55CDC antibody. BUBR1 or p55CDC immunoprecipitates, after three washes with the lysis buer and one wash with the kinase buer, were resuspended in the kinase buer (10 mM HEPES, using the baculoviral expression system (Pharmingen) following the manufacturer's protocol. Brie¯y, a cDNA fragment containing the entire open reading frame of human BUBR1 was cloned into pVL-1392 transfer vector. To facilitate puri®ca-tion of the recombinant protein, a short nucleotide sequence coding for six histidine residues was inserted in-frame immediately after the ATG codon of BUBR1 cDNA. The baculoviral expression vector BaculoGold TM DNA and the transfer plasmid pVL-1392-His6-BUBR1 were then cotransfected into insect sf-9 cells. His6-BUBR1 and His6-BUBR1 K795M were expressed in and puri®ed from sf-9 cells using Ni-NTA resins (Qiagen).
